Strategic Planning Lead (Immunology)

Location: Shanghai or Beijing, China

Company

Johnson & Johnson MedTech develops healthcare solutions and medical innovations across Innovative Medicine and MedTech.

What you will do

• Shape the integrated 3–5-year China Immunology strategy and provide strategic decision support to the division leadership.
• Assess pipeline assets, lifecycle opportunities, new indications, emerging modalities, and China-specific growth opportunities.
• Define portfolio, launch, investment, resource allocation, and capability priorities with China, AP, and Global stakeholders.
• Build outside-in strategic intelligence covering market trends, competition, policy, science, digital, and AI applications.
• Lead complex cross-functional transformation and special projects from problem definition through implementation and value realization.
• Support business development and external partnerships through strategic, commercial, risk, and execution assessments.

Requirements

• Minimum 10 years of progressive experience in pharmaceuticals, healthcare, management consulting, strategy, commercial, portfolio, or related functions.
• Experience leading complex cross-functional work and delivering high-impact outcomes in ambiguous environments.
• Strong understanding of the China pharmaceutical market, customer dynamics, access and policy environment, competition, and portfolio strategy.
• Substantial experience in strategy, portfolio planning, new product planning, transformation, strategic marketing, business development, or consulting.
• Professional communication in Chinese and English is required.
• Strong analytical thinking, executive communication, stakeholder influence, ownership, and collaboration skills.

Nice to have

• Experience in Immunology or specialty care.
• Experience with emerging science, new business models, digital tools, or AI-enabled commercial capabilities.

Culture & Benefits

• Inclusive environment based on individual dignity, diversity, and merit.
• Cross-functional collaboration across Commercial, Medical Affairs, Market Access, Finance, R&D, Regulatory, Digital, Operations, AP, and Global teams.
• Opportunity to influence China, Asia Pacific, and Global strategy in a patient-centered healthcare organization.